tiprankstipranks
Trending News
More News >
Helus Pharma (HELP)
NASDAQ:HELP
US Market

Helus Pharma (HELP) Financial Statements

Compare
2,327 Followers

Helus Pharma Financial Overview

Helus Pharma's market cap is currently $1.40M. The company's EPS TTM is $-0.995871861; its P/E ratio is -1.53; Helus Pharma is scheduled to report earnings on February 13, 2026, and the estimated EPS forecast is $-0.74. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 864.00K
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ -311.00K
Operating IncomeC$ -143.15MC$ -78.84MC$ -51.52MC$ -63.84MC$ -31.04M
EBITDAC$ -142.67MC$ -78.41MC$ -51.27MC$ -63.67MC$ -30.99M
Net IncomeC$ -113.14MC$ -78.08MC$ -47.49MC$ -67.63MC$ -32.22M
Balance Sheet
Cash & Short-Term InvestmentsC$ 135.02MC$ 208.99MC$ 16.63MC$ 53.64MC$ 64.03M
Total AssetsC$ 258.62MC$ 302.02MC$ 53.90MC$ 84.06MC$ 92.11M
Total DebtC$ 0.00C$ 291.00KC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -135.02MC$ -208.70MC$ -16.63MC$ -53.64MC$ -64.03M
Total LiabilitiesC$ 21.42MC$ 10.10MC$ 5.66MC$ 7.91MC$ 5.99M
Stockholders' EquityC$ 237.20MC$ 291.93MC$ 48.23MC$ 76.16MC$ 86.12M
Cash Flow
Free Cash FlowC$ -103.27MC$ -69.62MC$ -50.74MC$ -45.73MC$ -19.26M
Operating Cash FlowC$ -101.30MC$ -68.91MC$ -47.43MC$ -45.21MC$ -19.03M
Investing Cash FlowC$ -1.97MC$ 6.92MC$ -3.31MC$ -770.00KC$ -1.19M
Financing Cash FlowC$ 20.20MC$ 254.51MC$ 13.56MC$ 35.78MC$ 82.72M
Currency in CAD

Helus Pharma Earnings and Revenue History

Helus Pharma Debt to Assets

Helus Pharma Cash Flow

Helus Pharma Forecast EPS vs Actual EPS